Join our newsletter
Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM
Legitimation: Consent of the interested party
As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).
The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.
You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.
You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.
Cough suppressant related with morphine and codeine (d-isomer of the codeine analog of levorphanol) which is lacking of analgesic, sedative or respiratory depression properties (Schaefer 2007, Bem 1992), except in case of overdose or abuse (Journey 2019, WHO 2012, Pender 1991). Commonly prescribed by pediatricians.
Dextromethorphan and its active metabolite, dextrorphan, are excreted in breast milk in clinically insignificant amounts. (Shum 2021)
Because reported low toxicity and mild side effect, expert authors consider it safe, probably compatible during lactation. (Hale 2019, Briggs 2017, Schaefer 2007)
Frequently associated to caffeine and other products that are usually compatible with breastfeeding. It is advisable to avoid preparations with excessive alcohol concentration (> 20%) as excipient. (Nice 2000)